| DC24209 |
MDK7229(MD2-IN-1)
Featured
|
MDK7229, also known as MD2-IN-1 is a MD2 (Myeloid differentiation protein 2) inhibitor. |
|
| DC10570 |
MDK74978（Multi-kinase inhibitor）
Featured
|
MDK74978, also known as Multi-kinase inhibitor I, is a Multi-kinase inhibitor. MDK74978 has CAS#778274-97-8. The last 5 digit was used in its name. |
|
| DC12028 |
MDK7526(Protein degrader 1)
Featured
|
MDK7526, also known as VHL Ligand 1; Protein degrader 1, is a potent and selective protein degrader. |
|
| DC10571 |
MDK-8582（Hnps-PLA Inhibitor）
Featured
|
MDK-8582, also known as Hnps-PLA Inhibitor, is an nhibitor of human nonpancreatic secretory Phospholipase A (hnps-PLA). |
|
| DC7194 |
MDL 29951
Featured
|
MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo. |
|
| DC5069 |
Enzalutamide (MDV3100)
Featured
|
MDV3100 is an androgen-receptor (AR) antagonist with IC50 of 36 nM. |
|
| DC10650 |
MDVN1003
Featured
|
MDVN1003 is a potent inhibitor of BTK amd PI3K delta. |
|
| DC11141 |
ME0328
Featured
|
ME0328 is an inhibitor of PARP3 (IC50 = 0.89 µM), which is a regulator of DNA repair and mitotic progression. |
|
| DC23739 |
Meayamycin |
Meayamycin is an analogue of FR901464 that binds to the splicing factor 3b (SF3b) complex and inhibits pre-mRNA splicing, shows picomolar antiproliferative activity against various cancer cell lines and multidrug-resistant cells.. |
|
| DC10258 |
Mebendazole |
Mebendazole is a synthetic benzimidazole derivate and anthelmintic agent. Mebendazole interferes with the reproduction and survival of helminths by inhibiting the formation of their cytoplasmic microtubules, thereby selectively and irreversibly blocking g |
|
| DCAPI1081 |
Mecarbinate |
Mecarbinate |
|
| DC7757 |
(R)-Meclizine |
Meclizine is a histamine H1 receptor antagonist used to treat nausea and motion sickness. |
|
| DC9035 |
Meclofenoxate HCl |
Meclofenoxate hydrochloride, an ester of dimethylethanolamine (DMAE) and 4-chlorophenoxyacetic acid (pCPA), has been shown to improve memory, have a mentally stimulating effect, and improve general cognition. |
|
| DCAPI1580 |
Medetomidine |
Medetomidine hydrochloride is a potent and highly selective α2-AR adrenoceptor agonist (Ki values are 1.08 and 1750 nM for α2- and α1-adrenoceptors respectively). Shows greater selectivity over α1-adrenoceptors than clonidine and UK 14,304 (1620-, 220- an |
|
| DC20446 |
Mefuparib hydrochloride(CVL218)
Featured
|
Mefuparib(CVL218) hydrochloride is a potent, highly selective, competitive PARP1/2 inhibitor with IC50 of 3.2/1.9 nM, respectively.CVL218 was more potent than Remdesivir in blocking Coronavirus infection of cells and equally as potent as Remdesivir in blocking replication of virus once it has entered the cells. |
|
| DC7461 |
Meisoindigo
Featured
|
Meisoindigo(Natura-α; N-Methylisoindigotin; Dian III), a derivative of Indigo naturalis, might induce apoptosis and myeloid differentiation of acute myeloid leukemia (AML). |
|
| DC26032 |
Melagatran |
Melagatran is a synthetic, small-peptide direct thrombin inhibitor with anticoagulant activity. |
|
| DC11083 |
Dersimelagon
Featured
|
Dersimelagon, also known as MT-7117 and WHO 10832, is a novel, orally-administered, small molecule, selective melanocortin-1 receptor (MC1R) agonist that increases skin melanin without sun exposure and is being developed to increase light tolerance in EPP/XLP patients. Dersimelagon significantly boosted sunlight tolerance in patients with erythropoietic protoporphyria in a multicenter, phase 2, randomized trial.
|
.jpg)
|
| DC11353 |
MIF-1 |
Melanocyte-stimulating hormone release-inhibiting factor (MSH-R-IF) is a hypothalamic tripeptide that binds to rat striatum (Kd = 4.69 nM) and has diverse biological activities. |
|
| DC8311 |
Meleagrin |
Meleagrin is an antibiotic derived from a deep ocean, penicillin-producingP. chrysogenum. |
|
| DC21274 |
Melflufen |
Melflufen (Melphalan flufenamide, J1) is a novel dipeptide and alkylating prodrug of melphalan, inhibits angiogenesis in vitro and in vivo. |
|
| DC21917 |
MELK inhibitor 17 |
MELK inhibitor 17 is a potent, selective MELK inhibitor with Ki/IC50 of 0.39/3 nM, >100-fold selectivity over CHK1, CAMKK2, NUAK1 and ERK2. |
|
| DC10015 |
MELK-8a
Featured
|
MELK-8a is a novel MELK inhibitor. |
|
| DC11465 |
MELK-T1
Featured
|
MELK-T1 is a potent and selective inhibitor of protein kinase MELK. |
|
| DCAPI1316 |
Meloxicam (Mobic) |
Meloxicam (Mobic) |
|
| DC9050 |
Melphalan
Featured
|
Melphalan(Sarcolysin; L-PAM) is a chemotherapy drug belonging to the class of nitrogen mustard alkylating agents; attaches the alkyl group to the guanine base of DNA. |
|
| DC9526 |
Meptazinol (hydrochloride)
Featured
|
Meptazinol Hcl(WY-22811 Hcl) is a unique centrally active opioid analgesic.
|
|
| DC10407 |
Mequitazine |
Mequitazine is a potent, nonsedative and long-acting histamine H1 antagonist. |
|
| DC7195 |
JAK Inhibitor I(Merck 5, Pyridone 6)
Featured
|
Merck 5 is a potent and reversible ATP-competitive inhibitor of the JAK kinases (JAK1, JAK2, JAK3, and Tyk2). It also blocks IL2 and IL4 dependent proliferation of CTLL cells and inhibits the phosphorylation of STAT5. |
|
| DC22506 |
Merck60
Featured
|
Merck60 (BRD 6929, Compound-60) is a potent, selective and brain-penetrant inhibitor of HDAC1 and HDAC2 with IC50 of 1 nM and 8 nM respectively. |
|
